financial statements 133 Hikma PHarmaceuticals Plc annual report 2011 29. financial policies for risk management and their objectives Continued liquidity risk of assets liabilities less than two to more than one year five years five years total 2011 $000 $000 $000 $000 cash and cash equivalents 94,715 94,715 trade receivables 292,100 292,100 interest-bearing loans and borrowings 149,240 298,954 74,957 523,151 interest-bearing overdrafts 18,563 18,563 interest-bearing finance lease 3,490 19,315 22,805 trade payables 97,756 97,756 117,766 318,269 74,957 275,460 less than two to more than one year five years five years total 2010 $000 $000 $000 $000 cash and cash equivalents 62,718 62,718 trade receivables 200,334 200,334 interest-bearing loans and borrowings 69,678 76,073 4,569 150,320 interest-bearing overdrafts 14,699 14,699 interest-bearing finance lease 2,403 6,358 8,761 trade payables 74,936 74,936 101,336 82,431 4,569 14,336 see note 2. at 31 December 2011 the Group had undrawn facilities of usD 396,459,000 2010: usD 264,857,000.
Of these facilities, usD 258,615,000 2010: usD 130,752,000 was committed and the remainder was uncommitted.
30. derivative financial instruments currency derivatives the Group utilises currency derivatives to hedge significant future transactions and cash flows.
the Group is party to a variety of foreign currency forward contracts and options in the management of its exchange rate exposures.
the instruments purchased are primarily denominated in the currencies of the Groups principal markets.
at the balance sheet date, the total notional amount of outstanding forward foreign exchange contracts that the Group was committed to have been translated at 31 December exchange rates as below.
2011 2010 $000 $000 foreign exchange forward contracts and options euro 4,031 4,780 foreign exchange forward contracts and options jpy 6,000 these arrangements are designed to address significant exchange exposures.
at 31 December 2011, the fair value of the Groups currency derivatives, some of which were designated as effective cash flow hedges, was a liability of usD 187,000 2010: an asset of usD 83,000. the movement in fair value in the year resulted in a loss of usD 270,000 2010: gain of usD 83,000, which has been reflected in equity.
these amounts are based on market values of equivalent instruments at the balance sheet date.
the fair value of currency derivatives designated as ineffective cash flow hedges was nil 2010 assets of: 8,000 held at fair value through profit and loss.
the movement in fair value in the year resulted in a loss of usD 8,000 which has been recognised in the statement of comprehensive income for the year ended 31 December 2011 2010: gain of 8,000 in respect of such derivatives.
the Group believes that the effect on the value of cash flow hedges of currency fluctuations is not significant and will not materially affect the financial position of the Group.
